Drug Information Association Logo
Corporate Tagline

Session 3 - Drug Safety in China - The Importance of What's Happening

Track:
General Session

Day & Time:
January 13, 1:30PM - 3:00PM

Type:
Session

Title:
Session 3 - Drug Safety in China - The Importance of What's Happening

Chair(s):
Stewart Geary, MD
Senior Vice President, Chief Medical Officer
Eisai Co., Ltd., Japan

Description:
Session 3 - Drug Safety in China - The Importance of What's Happening

Presentation(s) & Speaker(s):
PV in China: The Current Landscape
Vera Liang, MD
Director and Global Safety Risk Lead, Safety Surveillance and Risk Management
Pfizer (China) R&D Co., Ltd., China

CRO Perspective
Deirdre McCarthy, MS
Director, Integrated Post-marketing and QPPV Services, Customer Safety Services
Quintiles Ireland, Ireland

Industry Perspective
William W. Gregory, PhD
Senior Director, Worldwide Safety and Regulatory
Pfizer Inc, United States